what just happened, page-30

May also like to check Noam Gavreily. A LOT of empirical research done in develpment of this one. I have asthma so i know a bit about it from the customer side. This looks good. Non invasive / not drug based = low barrier to FDA approval. Israel = Not likely to blow up money into thin air. Now maybe thats a stereotype but perhaps, just perhaps theres a grain of truth in it.

Disclosure - in at .11c. Nothing ventured nothing gained.